▶ 調査レポート

パレコキシブナトリウムの世界市場レポート2020

• 英文タイトル:Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。パレコキシブナトリウムの世界市場レポート2020 / Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Report 2020 / QY20ST-06979資料のイメージです。• レポートコード:QY20ST-06979
• 出版社/出版日:QYResearch / 2020年9月25日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥560,000 (USD4,000)▷ お問い合わせ
  Multi User¥840,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,120,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界のパレコキシブナトリウム市場について種類別(原薬、ジェネリック医薬品)、用途別(病院薬局、小売薬局、オンライン薬局)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・パレコキシブナトリウム市場の概要
・世界の主要地域別パレコキシブナトリウム市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のパレコキシブナトリウム市場規模2015-2026:種類別(原薬、ジェネリック医薬品)
・世界のパレコキシブナトリウム市場規模2015-2026:用途別(病院薬局、小売薬局、オンライン薬局)
・パレコキシブナトリウムの北米市場規模2015-2020
・パレコキシブナトリウムのヨーロッパ市場規模2015-2020
・パレコキシブナトリウムの中国市場規模2015-2020
・パレコキシブナトリウムの日本市場規模2015-2020
・パレコキシブナトリウムの東南アジア市場規模2015-2020
・パレコキシブナトリウムのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・パレコキシブナトリウムの製造コスト分析
・販売チャネル、流通業者、顧客
・パレコキシブナトリウムの市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Parecoxib Sodium (CAS 198470-85-8) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Parecoxib Sodium (CAS 198470-85-8), C19H17N2NaO4S, the formula weight is 392.40, and its form is white solid.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Parecoxib Sodium (CAS 198470-85-8) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Parecoxib Sodium (CAS 198470-85-8) industry.
Based on our recent survey, we have several different scenarios about the Parecoxib Sodium (CAS 198470-85-8) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Parecoxib Sodium (CAS 198470-85-8) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Parecoxib Sodium (CAS 198470-85-8) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Parecoxib Sodium (CAS 198470-85-8) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Parecoxib Sodium (CAS 198470-85-8) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Parecoxib Sodium (CAS 198470-85-8) market. The report also includes nautical information, where it shows Parecoxib Sodium (CAS 198470-85-8) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Parecoxib Sodium (CAS 198470-85-8) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Parecoxib Sodium (CAS 198470-85-8) market.
Parecoxib sodium is used for short-term treatment of postoperative pain.
Geographical Analysis:
Based on region, the global Parecoxib Sodium (CAS 198470-85-8) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Parecoxib Sodium (CAS 198470-85-8) market are
Pfizer
Sailong Pharma
Chiarai Tianqing
Qilu Pharma
Kelun Pharma

Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Parecoxib Sodium (CAS 198470-85-8) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Parecoxib Sodium (CAS 198470-85-8) market.
• The market share of the global Parecoxib Sodium (CAS 198470-85-8) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Parecoxib Sodium (CAS 198470-85-8) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Parecoxib Sodium (CAS 198470-85-8) market.

レポート目次

1 Parecoxib Sodium (CAS 198470-85-8) Market Overview
1.1 Parecoxib Sodium (CAS 198470-85-8) Product Scope
1.2 Parecoxib Sodium (CAS 198470-85-8) Segment by Type
1.2.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2020-2026)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Parecoxib Sodium (CAS 198470-85-8) Segment by Application
1.3.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Parecoxib Sodium (CAS 198470-85-8) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate (2015-2026)
1.4.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2015-2026)
1.4.3 Global Parecoxib Sodium (CAS 198470-85-8) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Parecoxib Sodium (CAS 198470-85-8) Industry Impact
1.5.1 How the Covid-19 is Affecting the Parecoxib Sodium (CAS 198470-85-8) Industry
1.5.1.1 Parecoxib Sodium (CAS 198470-85-8) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Parecoxib Sodium (CAS 198470-85-8) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Parecoxib Sodium (CAS 198470-85-8) Players to Combat Covid-19 Impact

2 Parecoxib Sodium (CAS 198470-85-8) Estimate and Forecast by Region
2.1 Global Parecoxib Sodium (CAS 198470-85-8) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Parecoxib Sodium (CAS 198470-85-8) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2015-2020)
2.2.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region (2015-2020)
2.3 Global Parecoxib Sodium (CAS 198470-85-8) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2015-2026)
2.4.2 Europe Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2015-2026)
2.4.3 China Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2015-2026)
2.4.4 Japan Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2015-2026)
2.4.6 India Parecoxib Sodium (CAS 198470-85-8) Estimates and Projections (2015-2026)
3 Global Parecoxib Sodium (CAS 198470-85-8) Competition Landscape by Players
3.1 Global Top Parecoxib Sodium (CAS 198470-85-8) Players by Sales (2015-2020)
3.2 Global Top Parecoxib Sodium (CAS 198470-85-8) Players by Revenue (2015-2020)
3.3 Global Parecoxib Sodium (CAS 198470-85-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parecoxib Sodium (CAS 198470-85-8) as of 2019)
3.4 Global Parecoxib Sodium (CAS 198470-85-8) Average Price by Company (2015-2020)
3.5 Manufacturers Parecoxib Sodium (CAS 198470-85-8) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Parecoxib Sodium (CAS 198470-85-8) Players (Opinion Leaders)
4 Global Parecoxib Sodium (CAS 198470-85-8) Market Size by Type
4.1 Global Parecoxib Sodium (CAS 198470-85-8) Historic Market Review by Type (2015-2020)
4.1.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
4.1.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Type (2015-2020)
4.1.3 Global Parecoxib Sodium (CAS 198470-85-8) Price by Type (2014-2020)
4.2 Global Parecoxib Sodium (CAS 198470-85-8) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Type (2021-2026)
4.2.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Type (2021-2026)
4.2.3 Global Parecoxib Sodium (CAS 198470-85-8) Price Forecast by Type (2021-2026)
5 Global Parecoxib Sodium (CAS 198470-85-8) Market Size by Application
5.1 Global Parecoxib Sodium (CAS 198470-85-8) Historic Market Review by Application (2015-2020)
5.1.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)
5.1.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Application (2015-2020)
5.1.3 Global Parecoxib Sodium (CAS 198470-85-8) Price by Application (2015-2020)
5.2 Global Parecoxib Sodium (CAS 198470-85-8) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Application (2021-2026)
5.2.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Application (2021-2026)
5.2.3 Global Parecoxib Sodium (CAS 198470-85-8) Price Forecast by Application (2021-2026)

3 North America Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures
3.2 North America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
3.3 North America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
3.4 North America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)

4 Europe Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures
4.2 Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
4.3 Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
4.4 Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)

5 China Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures
5.2 China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
5.3 China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
5.4 China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)

6 Japan Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures
6.2 Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
6.3 Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
6.4 Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)

7 Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures
7.2 Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)

8 India Parecoxib Sodium (CAS 198470-85-8) Market Facts & Figures
8.2 India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
8.3 India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
8.4 India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Parecoxib Sodium (CAS 198470-85-8) Business
12.1 Pfizer
12.1.1 Pfizer Parecoxib Sodium (CAS 198470-85-8) Corporation Information
12.1.2 Pfizer Parecoxib Sodium (CAS 198470-85-8) Business Overview and Total Revenue
12.1.3 Pfizer Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Parecoxib Sodium (CAS 198470-85-8) Products Offered
12.1.5 Pfizer Recent Development
12.2 Sailong Pharma
12.2.1 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Corporation Information
12.2.2 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Business Overview and Total Revenue
12.2.3 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Products Offered
12.2.5 Sailong Pharma Recent Development
12.3 Chiarai Tianqing
12.3.1 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Corporation Information
12.3.2 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Business Overview and Total Revenue
12.3.3 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Products Offered
12.3.5 Chiarai Tianqing Recent Development
12.4 Qilu Pharma
12.4.1 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Corporation Information
12.4.2 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Business Overview and Total Revenue
12.4.3 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Products Offered
12.4.5 Qilu Pharma Recent Development
12.5 Kelun Pharma
12.5.1 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Corporation Information
12.5.2 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Business Overview and Total Revenue
12.5.3 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Products Offered
12.5.5 Kelun Pharma Recent Development

13 Parecoxib Sodium (CAS 198470-85-8) Manufacturing Cost Analysis
13.1 Parecoxib Sodium (CAS 198470-85-8) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Parecoxib Sodium (CAS 198470-85-8)
13.4 Parecoxib Sodium (CAS 198470-85-8) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Parecoxib Sodium (CAS 198470-85-8) Distributors List
14.3 Parecoxib Sodium (CAS 198470-85-8) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Parecoxib Sodium (CAS 198470-85-8) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Parecoxib Sodium (CAS 198470-85-8) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Parecoxib Sodium (CAS 198470-85-8) Players to Combat Covid-19 Impact
Table 8. Global Market Parecoxib Sodium (CAS 198470-85-8) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Region (2015-2020)
Table 10. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2015-2020)
Table 11. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Region (2015-2020)
Table 13. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Parecoxib Sodium (CAS 198470-85-8) (Kg) of Key Companies (2015-2020)
Table 18. Global Parecoxib Sodium (CAS 198470-85-8) Sales Share by Company (2015-2020)
Table 19. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Company (2015-2020)
Table 21. Global Parecoxib Sodium (CAS 198470-85-8) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parecoxib Sodium (CAS 198470-85-8) as of 2019)
Table 22. Global Parecoxib Sodium (CAS 198470-85-8) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Parecoxib Sodium (CAS 198470-85-8) Manufacturing Sites and Area Served
Table 24. Manufacturers Parecoxib Sodium (CAS 198470-85-8) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Parecoxib Sodium (CAS 198470-85-8) Players
Table 27. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020)
Table 28. Global Parecoxib Sodium (CAS 198470-85-8) Sales Share by Type (2015-2020)
Table 29. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Parecoxib Sodium (CAS 198470-85-8) Price (Kg) by Type (2015-2020)
Table 31. Global Parecoxib Sodium (CAS 198470-85-8) Sales Share by Type (2021-2026)
Table 32. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Type (2021-2026)
Table 34. Global Parecoxib Sodium (CAS 198470-85-8) Price (Kg) by Type (2021-2026)
Table 35. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Application (2015-2020)
Table 36. Global Parecoxib Sodium (CAS 198470-85-8) Sales Share by Application (2015-2020)
Table 37. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Parecoxib Sodium (CAS 198470-85-8) Price (Kg) by Application (2015-2020)
Table 39. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Application (2021-2026)
Table 40. Global Parecoxib Sodium (CAS 198470-85-8) Sales Share by Application (2021-2026)
Table 41. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Application (2021-2026)
Table 43. Global Parecoxib Sodium (CAS 198470-85-8) Price (Kg) by Application (2021-2026)
Table 44. United States Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Company (2015-2020)
Table 45. United States Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
Table 46. United States Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020)
Table 47. United States Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
Table 48. United States Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Application (2015-2020)
Table 49. United States Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)
Table 50. Europe Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Company (2015-2020)
Table 51. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
Table 52. Europe Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020)
Table 53. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
Table 54. Europe Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Application (2015-2020)
Table 55. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
Table 56. China Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Company (2015-2020)
Table 57. China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
Table 58. China Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020)
Table 59. China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
Table 60. China Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Application (2015-2020)
Table 61. China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)
Table 62. Japan Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Company (2015-2020)
Table 63. Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
Table 64. Japan Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020)
Table 65. Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
Table 66. Japan Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Application (2015-2020)
Table 67. Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)
Table 74. India Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Company (2015-2020)
Table 75. India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2015-2020)
Table 76. India Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Type (2015-2020)
Table 77. India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2015-2020)
Table 78. India Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) by Application (2015-2020)
Table 79. India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2015-2020)
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Pfizer Parecoxib Sodium (CAS 198470-85-8) Product
Table 84. Pfizer Recent Development
Table 85. Sailong Pharma Corporation Information
Table 86. Sailong Pharma Description and Business Overview
Table 87. Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Product
Table 89. Sailong Pharma Recent Development
Table 90. Chiarai Tianqing Corporation Information
Table 91. Chiarai Tianqing Description and Business Overview
Table 92. Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Product
Table 94. Chiarai Tianqing Recent Development
Table 95. Qilu Pharma Corporation Information
Table 96. Qilu Pharma Description and Business Overview
Table 97. Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Product
Table 99. Qilu Pharma Recent Development
Table . Kelun Pharma Corporation Information
Table . Kelun Pharma Description and Business Overview
Table . Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Product
Table . Kelun Pharma Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Parecoxib Sodium (CAS 198470-85-8) Distributors List
Table 108. Parecoxib Sodium (CAS 198470-85-8) Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Parecoxib Sodium (CAS 198470-85-8) Product Picture
Figure 2. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Parecoxib Sodium (CAS 198470-85-8) Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Parecoxib Sodium (CAS 198470-85-8) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Parecoxib Sodium (CAS 198470-85-8) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Parecoxib Sodium (CAS 198470-85-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Parecoxib Sodium (CAS 198470-85-8) Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Parecoxib Sodium (CAS 198470-85-8) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Parecoxib Sodium (CAS 198470-85-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Parecoxib Sodium (CAS 198470-85-8) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Parecoxib Sodium (CAS 198470-85-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Parecoxib Sodium (CAS 198470-85-8) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Parecoxib Sodium (CAS 198470-85-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Parecoxib Sodium (CAS 198470-85-8) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Parecoxib Sodium (CAS 198470-85-8) Players Market Share by Revenue in Parecoxib Sodium (CAS 198470-85-8) 2015 & 2019
Figure 27. Parecoxib Sodium (CAS 198470-85-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Type (2015-2020)
Figure 29. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Share by Application (2015-2020)
Figure 31. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2019
Figure 33. United States Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2019
Figure 34. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company in 2019
Figure 35. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2019
Figure 36. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application in 2019
Figure 37. China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company in 2019
Figure 38. China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2019
Figure 39. China Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application in 2019
Figure 40. Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company in 2019
Figure 41. Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2019
Figure 42. Japan Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application in 2019
Figure 46. India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company in 2019
Figure 47. India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2019
Figure 48. India Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application in 2019
Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sailong Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Chiarai Tianqing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Qilu Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Kelun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Parecoxib Sodium (CAS 198470-85-8)
Figure 56. Manufacturing Process Analysis of Parecoxib Sodium (CAS 198470-85-8)
Figure 57. Parecoxib Sodium (CAS 198470-85-8) Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed